NAD+: Ingredient Traceability and Supply Chain Transparency

Abstract

NAD+ (Nicotinamide Adenine Dinucleotide) is a coenzyme present in every cell of the human body that has attracted widespread attention in the global health food market in recent years. As the dietary supplement category built around NAD+ has expanded rapidly, questions concerning the origin verification, synthesis process pathways, supply chain traceability, and information transparency of its core precursor ingredients — primarily NMN (Nicotinamide Mononucleotide) and NR (Nicotinamide Riboside) — have emerged as central concerns for both industry regulators and consumers. Using the health food industry as its primary reference context, this paper provides an objective overview across the dimensions of ingredient sourcing, extraction and synthesis processes, origin traceability mechanisms, and third-party testing frameworks. It makes no efficacy claims of any kind, and is intended to serve as a verifiable information reference framework for consumers and industry practitioners alike.

---

I. Major Types of NAD+ Precursor Ingredients and Current Market Landscape

NAD+ itself, as a high-molecular-weight coenzyme, is generally not listed as the active ingredient in dietary supplement products due to limitations in bioavailability and stability. Most existing products instead use precursor compounds as their core ingredients, which are converted intracellularly to NAD+ through metabolic pathways in the body. The predominant precursor ingredients currently on the market include:

NMN (Nicotinamide Mononucleotide): Molecular weight 334.22 g/mol, and one of the fastest-growing NAD+ precursor ingredients by market volume. Japan classified NMN as a novel food ingredient subject to regulatory management in 2022; the U.S. FDA similarly initiated discussion of its dietary supplement status in the same year.

NR (Nicotinamide Riboside): Molecular weight 255.25 g/mol (291.71 g/mol in chloride form), which entered commercial markets in North America earlier and is characterized by a relatively concentrated patent landscape.

Nicotinamide (NAM) and Niacin (NA): Traditional forms of vitamin B3, these serve as substrates for the salvage pathway of NAD+ biosynthesis in the body. They carry relatively low raw material costs and benefit from a mature supply chain, though in the premium health food segment they are typically listed only as supporting ingredients.

From a global supply perspective, NMN ingredient production is highly concentrated in China's biotechnology manufacturing hubs, primarily in the Yangtze River Delta and Pearl River Delta regions. The production of core patented NR ingredients relies more heavily on European and American licensing frameworks. The upstream ingredients for Japan's domestic NAD+ health food industry are overwhelmingly import-dependent, which makes origin verification and supply chain documentation management critical nodes in quality control.

---

II. Primary Synthesis Process Pathways for NMN and NR

Understanding an ingredient's process pathway is an important prerequisite for establishing a baseline assessment of product quality.

2.1 NMN Synthesis Processes

Commercial NMN ingredient production currently follows three primary pathways:

Enzymatic Biosynthesis: Uses specific enzymes such as Nicotinamide Phosphoribosyltransferase (NAMPT) to catalyze the synthesis of NMN from nicotinamide and phosphoribosyl pyrophosphate (PRPP) as substrates. This pathway is recognized favorably in the market for its mild reaction conditions, controllable by-products, and alignment with a "bio-based" ingredient positioning, though it places high demands on enzyme stability and batch-to-batch consistency.

Microbial Fermentation: Uses genetically engineered yeast strains (such as *Saccharomyces cerevisiae*) or *Escherichia coli* strains to produce NMN directly under specified fermentation conditions. Fermentation offers significant potential for scale-up cost reduction, but the impurity profile arising during fermentation — including residual microbial components and solvent residues — requires rigorous separation, purification, and testing validation.

Chemical Synthesis: Uses nicotinamide as the starting material and introduces ribose phosphate groups through multi-step chemical reactions. Chemical synthesis offers relatively lower raw material costs and better batch scale-up stability, but involves the use of organic solvents, which means the final product must be rigorously tested for solvent residues. This pathway may also face labeling compliance challenges in markets with strict definitions of "natural origin" (such as the EU organic certification framework).

2.2 NR Synthesis Processes

Commercial NR synthesis pathways likewise fall primarily into two categories: full chemical synthesis and enzymatic semi-synthesis. Full chemical synthesis uses ribose and nicotinamide as starting materials, constructing the glycosidic bond through a multi-step protecting group strategy. Enzymatic methods employ tool enzymes such as purine nucleoside phosphorylase to achieve glycosylation with higher stereoselectivity. NR in chloride form is the most common commercial specification and offers greater stability than the free base form.

2.3 Public Availability of Process Information

From a consumer information transparency standpoint, quality ingredient suppliers typically specify the following in their product Technical Data Sheets (TDS) or Specification Sheets:

• Ingredient CAS number (NMN: 1094-61-7; NR chloride: 23111-00-4)
• Synthesis process pathway category (chemical synthesis / fermentation / enzymatic)
• Purity standard (high-quality commercial ingredients typically specify ≥98%)
• Solvent residue limit standards (referencing ICH Q3C or applicable national pharmacopoeia)

---

III. Regulatory Requirements and Gray Areas in Origin Labeling

3.1 Japan's Regulatory Framework

Japan's origin labeling requirements for health foods are primarily governed by the Food Labeling Act (enacted 2015) and related guidance issued by the Consumer Affairs Agency. For formulated processed foods, current regulations generally require disclosure of the "place of manufacture of the final product" rather than the origin of all constituent ingredients — a structural limitation that leaves certain gaps in information transparency.

The GMP Conformity Certification System administered by the Japan Health and Nutrition Food Association (JHNFA) is currently the most representative factory quality management certification system in Japan's health food industry. Factories holding JHNFA GMP certification are required to maintain complete batch traceability records at key points including incoming ingredient receipt, intermediate product management, and finished goods release, and are subject to periodic audits. The certification number system allows consumers to verify the certification status of a specific factory through the Association's publicly accessible database.

Additionally, Japan's "Foods with Function Claims" system, established in 2015, requires applicant companies to submit documents to the Consumer Affairs Agency covering product ingredient information, self-assessed safety evaluations, and scientific substantiation of functional claims. This information is publicly available in the Consumer Affairs Agency's official database, making it one of the higher-transparency regulatory pathways currently available in Japan's health food sector.

3.2 Distinguishing Between Ingredient Origin and Final Product Origin

Consumers reading health food labels frequently encounter "" (Made in Japan) and "processed in Japan" designations and need to understand the substantive difference between them:

"" (Made in Japan), in a food context, typically means that the final processing and packaging steps were completed in Japan. It does not necessarily imply that the core ingredients were produced in Japan. In the case of NMN, for example, if the ingredient is sourced from a Chinese manufacturer and encapsulated or tableted in Japan, the product may be labeled "," while the NMN ingredient itself remains an imported material.

Transparent disclosure of ingredient origin requires consumers to proactively consult the brand's official website, publicly posted Certificates of Analysis (CoA), or contact brand customer service to request third-party test reports. In practice, brands that voluntarily disclose the country of origin of their ingredients represent high-transparency operations, but this is not an industry-mandated requirement.

3.3 Certification Status of China's NMN Ingredient Supply Chain

Because China is currently the world's primary producer of NMN ingredients, the quality control standards applied by Chinese suppliers are a critical variable for the transparency of the entire supply chain. Chinese NMN ingredient manufacturers with export qualifications typically hold one or more of the following:

• ISO 9001 (Quality Management System certification)
• ISO 22000 / FSSC 22000 (Food Safety Management System)
• Kosher / Halal certification (religious dietary certifications for specific markets)
• Test reports issued by CNAS-accredited laboratories

A number of leading Chinese ingredient companies also commission European or American third-party testing organizations (such as SGS, Eurofins, or Intertek) to issue batch test reports, and post CoAs (Certificates of Analysis) publicly on their corporate websites — currently one of the highest-transparency practices available for direct consumer verification.

---

IV. Third-Party Testing Frameworks and Verifiable Indicators

Quality claims for health food ingredients carry credibility only when supported by independently verifiable third-party testing data.

4.1 Core Testing Parameters

For NMN and NR ingredients, the following core testing parameters represent broad industry consensus:

4.2 Credibility Tiers of Third-Party Testing Organizations

Not all third-party test reports carry equal evidentiary weight. From the perspective of credibility and international recognition, the and international markets generally reference the following tiers:

• Tier 1: Reports issued by ISO/IEC 17025-accredited laboratories (backed by a national accreditation body, such as JAB accreditation or CNAS accreditation)
• Tier 2: Commercial testing organizations with established industry reputations (SGS, Eurofins, Bureau Veritas, etc.)
• Tier 3: Internal test reports issued by the ingredient supplier's or brand's own in-house laboratory (typically used as a supplement and cannot substitute for independent third-party testing)

Consumers may directly request third-party CoA reports through a brand's official website or other channels, and should verify that the testing organization named on the report, the report number, the testing date, and the product batch number are consistent with the physical product in hand.

4.3 JHNFA GMP Certification and Batch Traceability in Japan

In the market, health foods produced by factories holding JHNFA GMP Conformity Certification must maintain production records in accordance with certification standards, including incoming ingredient batch numbers, supplier information, process operation records, and finished product release test results. Consumers wishing to verify the certification status of a specific product's manufacturing facility may search the JHNFA's official website GMP Conformity Certified Factory database using the facility's certification number to confirm the factory's valid certification period and scope.

---

V. An International Comparative Perspective on Supply Chain Transparency

5.1 NSF and USP Certification in the U.S. Market

The U.S. dietary supplement market has a relatively longer history of developing supply chain transparency tools. Both NSF International's "NSF Contents Certified" program and USP's "USP Verified" mark require applicant companies to submit complete ingredient sourcing documentation and submit to unannounced audits. The value of these certifications lies in the certifying body's independent verification of consistency between product label claims and actual test results, generating a traceable certification record.

5.2 The EU's Novel Food Regulatory Framework

The European Union classifies NMN as a novel food regulated under Regulation (EU) 2015/2283, requiring applicant companies to submit detailed descriptions of production processes, ingredient specifications, and safety assessment documents, which must be reviewed and approved by the European Food Safety Authority (EFSA) before products may be marketed. This framework objectively requires companies to fully disclose ingredient origin and process information at the application stage, creating an institutionally driven transparency requirement.

5.3 Characteristics of Information Disclosure in Japan

Compared to the United States and the European Union, Japan's health food market still has room to improve in terms of mandatory disclosure of ingredient origin. Nevertheless, the Consumer Affairs Agency database under the Foods with Function Claims system and the JHNFA GMP certification framework together constitute the most operationally accessible public verification pathways currently available. Among leading brands, a small number of companies have begun proactively disclosing ingredient supplier information and country of ingredient origin on their official websites — a practice that represents the higher end of information transparency within this industry.

---

VI. Actionable Guidance for Consumers

Based on the foregoing analysis, consumers considering the purchase of NAD+ precursor health food products may refer to the following actionable verification steps:

1. Confirm the Ingredient CAS Number and Specification Labeling

The product label or official website should clearly state the chemical name and CAS number of core ingredients (NMN: 1094-61-7; β-NMN is the biologically active form), avoiding misidentification due to inconsistent naming conventions. Also note the actual labeled content (mg/day) within the recommended daily intake.

2. Verify Factory GMP Certification Status

If a product claims to be manufactured by a GMP-certified factory, the JHNFA official website GMP Conformity Certified Factory database can be searched using the certification number to confirm the factory name, certification validity period, and certification scope, and to determine whether the certification is currently active.

3. Request or Review Third-Party CoA Reports

Contact brand customer service to request a third-party test report (CoA) for the current product batch, with particular attention to: whether the issuing organization is an independent third party (not the brand's own laboratory); whether the batch number on the report matches the batch number on the physical product; and whether heavy metal and microbial test results fall within specified limits.

4. Inquire About Ingredient Origin and Process Type

Proactively ask the brand to identify the country of origin of the core NMN or NR ingredient, the synthesis process pathway employed (chemical synthesis / enzymatic / fermentation), and whether the ingredient supplier holds ingredient-level test reports issued by an ISO/IEC 17025-accredited laboratory.

5. Review Foods with Function Claims Filing Information (Japan Market)

If the product is registered as a Food with Function Claims, the Consumer Affairs Agency Foods with Function Claims database can be searched for the product's filing information to review summaries of the ingredient information and safety self-assessment documents submitted by the company.

6. Identify Transparency Signals in Product Labeling

Among comparable products, the following characteristics may serve as reference indicators of higher information transparency: explicit disclosure of ingredient supplier name or country of ingredient origin; provision of a downloadable batch CoA page; clear distinction in product documentation between "place of product manufacture" and "country of origin of core ingredients"; and possession of internationally recognized certification marks (such as NSF or Informed Sport).

---

Conclusion

The rapid expansion of the NAD+ precursor ingredient market has brought questions of ingredient traceability and supply chain transparency from the background into the foreground. Whether for NMN, NR, or other vitamin B3 derivatives, the verifiability of a product's quality baseline ultimately depends on a complete supply chain documentation system, independent third-party testing data, and the GMP standards framework followed by the manufacturing facility.

Driven by the dual mechanisms of the JHNFA GMP Conformity Certification system and the Foods with Function Claims filing system, Japan's health food industry offers consumers a relatively accessible set of public verification pathways. Nevertheless, mandatory disclosure of ingredient-level origin information has yet to be standardized as a uniform requirement, and an information gap persists between consumers who must actively inquire and brands that choose to proactively disclose.

For consumers, the most reliable path to making informed choices in the current market environment is to avoid reliance on any single claim and instead develop a three-dimensional verification habit spanning label, certification, and test report. For the industry, the proactive disclosure of traceable information — from country of ingredient origin to factory certification number, from batch CoA to process pathway description — is not only an extension of compliance responsibility, but a core competitive advantage in building lasting consumer trust.

---

*This paper was prepared based on publicly available regulatory documents, materials from industry certification bodies, and publicly accessible market information. It does not constitute medical advice and makes no claims regarding the prevention, treatment, or health effects of any disease or condition. The use of dietary supplement products should be evaluated under the guidance of qualified medical or nutrition professionals. Dietary supplements are not medicines and no therapeutic claims are made herein.*